Envestnet Asset Management
TEVA icon

Envestnet Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Envestnet Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.7M Sell
1,702,176
-68,732
-4% -$2.29M 0.01% 806
2026
Q1 		$53.3M Buy
1,770,908
+822,035
+87% +$26.4M 0.01% 773
2025
Q4 		$29.6M Sell
948,873
-407,913
-30% -$10M 0.01% 1003
2025
Q3 		$27.4M Sell
1,356,786
-75,687
-5% -$1.33M 0.01% 1083
2025
Q2 		$24M Sell
1,432,473
-489,289
-25% -$7.9M 0.01% 1136
2025
Q1 		$29.5M Sell
1,921,762
-116,779
-6% -$2.09M 0.01% 954
2024
Q4 		$44.9M Sell
2,038,541
-68,650
-3% -$1.25M 0.01% 770
2024
Q3 		$38M Buy
2,107,191
+30,591
+1% +$535K 0.01% 845
2024
Q2 		$33.7M Buy
2,076,600
+207,533
+11% +$3.2M 0.01% 844
2024
Q1 		$26.4M Buy
1,869,067
+1,797,750
+2,521% +$22.7M 0.01% 953
2023
Q4 		$745K Buy
71,317
+29,948
+72% +$280K ﹤0.01% 3116
2023
Q3 		$422K Sell
41,369
-128,693
-76% -$1.2M ﹤0.01% 3338
2023
Q2 		$1.28M Sell
170,062
-801,022
-82% -$6.5M ﹤0.01% 2563
2023
Q1 		$2.11M Buy
971,084
+658,396
+211% +$6.51M ﹤0.01% 2169
2022
Q4 		$2.85M Sell
312,688
-94,765
-23% -$827K ﹤0.01% 1939
2022
Q3 		$3.29M Buy
407,453
+266,428
+189% +$2.36M ﹤0.01% 1776
2022
Q2 		$1.06M Buy
141,025
+57,121
+68% +$498K ﹤0.01% 2544
2022
Q1 		$788K Buy
83,904
+51,513
+159% +$430K ﹤0.01% 2833
2021
Q4 		$259K Sell
32,391
-9,415
-23% -$85K ﹤0.01% 3498
2021
Q3 		$407K Buy
41,806
+3,234
+8% +$30.3K ﹤0.01% 3104
2021
Q2 		$382K Sell
38,572
-27,282
-41% -$289K ﹤0.01% 3139
2021
Q1 		$760K Sell
65,854
-31,439
-32% -$361K ﹤0.01% 2595
2020
Q4 		$939K Buy
97,293
+13,812
+17% +$132K ﹤0.01% 2253
2020
Q3 		$752K Buy
83,481
+68,147
+444% +$721K ﹤0.01% 2198
2020
Q2 		$189K Buy
15,334
+2,389
+18% +$27K ﹤0.01% 2887
2020
Q1 		$116K Sell
12,945
-553
-4% -$5.67K ﹤0.01% 2831
2019
Q4 		$132K Buy
13,498
+1,574
+13% +$14.1K ﹤0.01% 2975
2019
Q3 		$82K Buy
+11,924
New +$91.4K ﹤0.01% 2967
2019
Q2 		– Sell
-85,318
Closed -$1.34M – 3074
2019
Q1 		$1.34M Buy
85,318
+39,583
+87% +$698K ﹤0.01% 1710
2018
Q4 		$705K Buy
+45,735
New +$938K ﹤0.01% 1940
2018
Q3 		– Sell
-1,729
Closed -$42K – 2474
2018
Q2 		$42K Buy
1,729
+731
+73% +$14.9K ﹤0.01% 2255
2018
Q1 		$17K Sell
998
-9,394
-90% -$183K ﹤0.01% 2410
2017
Q4 		$197K Sell
10,392
-11,520
-53% -$173K ﹤0.01% 1852
2017
Q3 		$387K Sell
21,912
-10,844
-33% -$244K ﹤0.01% 1579
2017
Q2 		$1.09M Sell
32,756
-4,645
-12% -$144K ﹤0.01% 1150
2017
Q1 		$1.2M Sell
37,401
-68,798
-65% -$2.35M ﹤0.01% 1137
2016
Q4 		$3.85M Sell
106,199
-60,146
-36% -$2.4M 0.01% 639
2016
Q3 		$7.65M Sell
166,345
-124,296
-43% -$6.49M 0.03% 437
2016
Q2 		$14.6M Sell
290,641
-8,890
-3% -$473K 0.06% 283
2016
Q1 		$16M Buy
299,531
+63,677
+27% +$3.74M 0.07% 245
2015
Q4 		$15.5M Sell
235,854
-8,960
-4% -$554K 0.07% 250
2015
Q3 		$13.8M Buy
244,814
+23,152
+10% +$1.5M 0.07% 239
2015
Q2 		$13.1M Buy
221,662
+9,023
+4% +$557K 0.06% 285
2015
Q1 		$13.2M Buy
212,639
+205,157
+2,742% +$11.9M 0.07% 277
2014
Q4 		$430K Buy
7,482
+131
+2% +$7.3K ﹤0.01% 746
2014
Q3 		$395K Buy
7,351
+437
+6% +$23.2K ﹤0.01% 847
2014
Q2 		$362K Sell
6,914
-3,042
-31% -$155K ﹤0.01% 838
2014
Q1 		$526K Sell
9,956
-958
-9% -$44.3K 0.01% 642
2013
Q4 		$437K Sell
10,914
-891
-8% -$35.1K 0.01% 657
2013
Q3 		$446K Buy
11,805
+1,726
+17% +$67.3K 0.01% 632
2013
Q2 		$395K Buy
+10,079
New +$393K 0.01% 645

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Envestnet Asset Management's TEVA Position: Q2 2026 in Review

Envestnet Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 3.9% in Q2 2026, selling an estimated $2.29M and leaving 1,702,176 shares worth $57.7M. The position accounts for 0.01% of the portfolio, ranked #806.

Envestnet Asset Management first reported a position in TEVA in Q2 2013 and has held it in 51 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Envestnet Asset Management held 1,702,176 shares of Teva Pharmaceuticals worth $57.7M as of Q2 2026.
  • Envestnet Asset Management sold 68,732 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.29M.
  • Teva Pharmaceuticals made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #806 holding.
  • Envestnet Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.